miR5083p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP7. Guo F, Zhang K, Li M, Cui L, et al. Int J Oncol 2020 Apr 27. doi: 10.3892/ijo.2020.5055.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guo F, Zhang K, Li M, Cui L, et al. miR5083p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP7. Int J Oncol 2020 Apr 27. doi: 10.3892/ijo.2020.5055.
PMID: 32377701